The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy.

AHC, Alternating Hemiplegia of Childhood ASM, Anti-Seizure Medication Alternating hemiplegia of childhood CNS, Central Nervous System E:I Ratio, Excitation: Inhibition Ratio EEG, Electroencephalography EMG, Electromyography EOG, Electrooculography FDI, First Dorsal Interosseus HD-EEG, High-Density EEG ICF, Intracortical Facilitation LICI, Long Interval Cortical Inhibition MEP, Motor Evoked Potential MRI, Magnetic Resonance Imaging MSO, Maximum Stimulator Output MT, Motor Threshold PWE, People with Epilepsy Paired pulse QoL, Quality of Life RMT, Resting Motor Threshold SCORE, Standardized Computer-based Organized Reporting of EEG SICI, Short-Interval Intracortical Inhibition Safety Single pulse TEP, TMS-evoked Potential TMS TMS, Transcranial Magnetic Stimulation ppTMS, Paired-pulse TMS rTMS, Repetitive TMS spTMS, Single-pulse TMS

Journal

Clinical neurophysiology practice
ISSN: 2467-981X
Titre abrégé: Clin Neurophysiol Pract
Pays: Netherlands
ID NLM: 101684308

Informations de publication

Date de publication:
2022
Historique:
received: 26 11 2021
revised: 21 04 2022
accepted: 17 05 2022
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

To elucidate the effects of single and paired-pulse TMS on seizure activity at electrographic and clinical levels in people with and without epilepsy. A cohort of 35 people with epilepsy, two people with alternating hemiplegia of childhood (AHC) with no epilepsy, and 16 healthy individuals underwent single or paired-pulse TMS combined with EEG. Clinical records and subject interviews were used to examine seizure frequency four weeks before and after TMS. There were no significant differences in seizure frequency in any subject after TMS exposure. There was no occurrence of seizures in healthy individuals, and no worsening of hemiplegic attacks in people with AHC. No significant changes in seizure activity were found before or after TMS. This study adds evidence on the safety of TMS in people with and without epilepsy with follow-up of four weeks after TMS.

Identifiants

pubmed: 35800886
doi: 10.1016/j.cnp.2022.05.005
pii: S2467-981X(22)00024-5
pmc: PMC9254260
doi:

Types de publication

Journal Article

Langues

eng

Pagination

174-182

Informations de copyright

© 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.

Références

Brain. 1987 Oct;110 ( Pt 5):1173-90
pubmed: 3676697
Epilepsy Res. 2018 Jan;139:73-79
pubmed: 29197668
Clin Ther. 2020 Jul;42(7):1155-1168
pubmed: 32624320
Rev Neurol (Paris). 2016 Feb;172(2):123-6
pubmed: 26857413
Electroencephalogr Clin Neurophysiol. 1992 Aug;85(4):265-72
pubmed: 1380914
Lancet. 1992 Feb 8;339(8789):362
pubmed: 1346431
Epilepsia. 2005 Apr;46(4):470-2
pubmed: 15816939
Med Biol Eng Comput. 1999 May;37(3):322-6
pubmed: 10505382
Ann Neurol. 2016 Nov;80(5):718-729
pubmed: 27717082
Epilepsia. 2020 Sep;61(9):1818-1839
pubmed: 32783192
Int J Law Psychiatry. 2012 Mar-Apr;35(2):121-9
pubmed: 22261319
Lancet. 2006 Apr 1;367(9516):1087-1100
pubmed: 16581409
Biomark Med. 2011 Oct;5(5):537-44
pubmed: 22003902
J Neurosci. 2009 Jun 17;29(24):7679-85
pubmed: 19535579
Neuroimage. 2010 Jan 15;49(2):1459-68
pubmed: 19770048
Nat Commun. 2018 Oct 24;9(1):4427
pubmed: 30356042
JAMA Neurol. 2018 Mar 1;75(3):279-286
pubmed: 29279892
Lancet Neurol. 2003 Mar;2(3):145-56
pubmed: 12849236
Electroencephalogr Clin Neurophysiol. 1995 Jan;94(1):19-25
pubmed: 7530636
Lancet. 2015 Mar 7;385(9971):884-98
pubmed: 25260236
Epilepsia. 2017 May;58(5):901-906
pubmed: 28374950
Brain Res Rev. 2006 Aug 30;52(1):183-92
pubmed: 16545462
Mult Scler. 2004 Aug;10(4):475-6
pubmed: 15327050
Clin Neurophysiol. 2015 Jun;126(6):1071-1107
pubmed: 25797650
Nat Genet. 2012 Sep;44(9):1030-4
pubmed: 22842232
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
Lancet Neurol. 2011 May;10(5):446-56
pubmed: 21511198
Clin Neurophysiol. 2004 Dec;115(12):2728-37
pubmed: 15546781
Clin Neurophysiol. 2016 Sep;127(9):3025-3032
pubmed: 27472537
Arch Gen Psychiatry. 2012 Aug;69(8):766-74
pubmed: 22474071
Neurology. 1990 Jul;40(7):1132-3
pubmed: 2113205
Clin Neurophysiol. 2021 Jan;132(1):269-306
pubmed: 33243615
Brain Cogn. 2002 Dec;50(3):387-95
pubmed: 12480485
J Physiol. 1993 Nov;471:501-19
pubmed: 8120818
Lancet. 1989 Nov 18;2(8673):1223
pubmed: 2572937
Int J Neural Syst. 2015 Aug;25(5):1550018
pubmed: 25986753
Clin Neurophysiol. 2017 Feb;128(2):367-381
pubmed: 28007469
Acta Neurol Scand. 1996 Jul;94(1):24-30
pubmed: 8874589
J ECT. 2005 Sep;21(3):188-9
pubmed: 16127313
Electroencephalogr Clin Neurophysiol. 1998 Jan;108(1):1-16
pubmed: 9474057
Epilepsia. 2002 May;43(5):535-8
pubmed: 12027916
Int J Neural Syst. 2014 Mar;24(2):1430001
pubmed: 24475894
Science. 2005 Sep 30;309(5744):2228-32
pubmed: 16195466
Brain. 2018 Feb 1;141(2):409-421
pubmed: 29340584
Curr Opin Neurol. 2014 Apr;27(2):236-41
pubmed: 24553462
J ECT. 2011 Mar;27(1):48-50
pubmed: 20351571
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Clin Neurophysiol. 2019 Aug;130(8):1409-1416
pubmed: 31104898
Seizure. 2017 Jan;44:206-210
pubmed: 27640741
Clin Neurophysiol. 2019 May;130(5):802-844
pubmed: 30772238
Clin Neurophysiol. 2020 May;131(5):1019-1020
pubmed: 32193163
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
Lancet. 1985 May 11;1(8437):1106-7
pubmed: 2860322
PLoS One. 2010 Apr 22;5(4):e10281
pubmed: 20421968

Auteurs

Serena Pang (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Sasha D'Ambrosio (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Giulia Battaglia (G)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Diego Jiménez-Jiménez (D)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
School of Medicine, Universidad San Francisco de Quito, Quito, Ecuador.

Marco Perulli (M)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
Child Neurology and Psychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Department of Neuroscience, Catholic University Of The Sacred Heart, Rome, Italy.

Katri Silvennoinen (K)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Sara Zagaglia (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.

Simona Balestrini (S)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, and Epilepsy Society, Chalfont-St-Peter, Bucks, UK.
Neuroscience Department, Children's Hospital Meyer-University of Florence, Florence, Italy.

Classifications MeSH